These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 17929214

  • 1. [Rational use of catecholamines and inotropes].
    Hewing B, Stangl K.
    Pneumologie; 2007 Nov; 61(11):700-8. PubMed ID: 17929214
    [Abstract] [Full Text] [Related]

  • 2. Review of current and investigational pharmacologic agents for acute heart failure syndromes.
    Shin DD, Brandimarte F, De Luca L, Sabbah HN, Fonarow GC, Filippatos G, Komajda M, Gheorghiade M.
    Am J Cardiol; 2007 Jan 22; 99(2A):4A-23A. PubMed ID: 17239703
    [Abstract] [Full Text] [Related]

  • 3. New catecholamines in clinical cardiovascular medicine.
    Leier CV.
    Kardiol Pol; 1980 Jan 22; 23(9):721-5. PubMed ID: 7441942
    [No Abstract] [Full Text] [Related]

  • 4. [Enoximone--clinical experiences in heart surgery].
    Krüger AD, Francke A, Emmrich K.
    Anaesthesiol Reanim; 1996 Jan 22; 21(3):60-8. PubMed ID: 8766397
    [Abstract] [Full Text] [Related]

  • 5. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes.
    Bayram M, De Luca L, Massie MB, Gheorghiade M.
    Am J Cardiol; 2005 Sep 19; 96(6A):47G-58G. PubMed ID: 16181823
    [Abstract] [Full Text] [Related]

  • 6. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
    Weber KT, Janicki JS, Jain MC.
    J Heart Transplant; 1986 Sep 19; 5(2):105-12. PubMed ID: 2956397
    [Abstract] [Full Text] [Related]

  • 7. [Pharmacotherapy of severe heart failure with inodilators--new approaches].
    Baumann G, Hader O.
    Z Kardiol; 1996 Sep 19; 85 Suppl 4():9-19. PubMed ID: 9027110
    [Abstract] [Full Text] [Related]

  • 8. Inotropes in the management of acute heart failure.
    Petersen JW, Felker GM.
    Crit Care Med; 2008 Jan 19; 36(1 Suppl):S106-11. PubMed ID: 18158469
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The use of more than one inotrope in acute heart failure is associated with increased mortality: a multi-centre observational study.
    Rossinen J, Harjola VP, Siirila-Waris K, Lassus J, Melin J, Peuhkurinen K, Nieminen MS.
    Acute Card Care; 2008 Jan 19; 10(4):209-13. PubMed ID: 18720087
    [Abstract] [Full Text] [Related]

  • 11. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
    El Mokhtari NE, Arlt A, Meissner A, Lins M.
    Eur J Med Res; 2007 Nov 05; 12(11):563-7. PubMed ID: 18024265
    [Abstract] [Full Text] [Related]

  • 12. [Hemodynamic effects of amrinone, dobutamine and dopamine in the cardiac low output syndrome following open-heart surgery].
    Husedzinović I, Rumboldt Z, Ivancan V, Nikić N, Rudeź I, Biocina B, Sutlić Z.
    Lijec Vjesn; 1995 Jun 05; 117 Suppl 2():32-4. PubMed ID: 8649147
    [Abstract] [Full Text] [Related]

  • 13. Overview of randomized clinical trials in acute heart failure syndromes.
    Teerlink JR.
    Am J Cardiol; 2005 Sep 19; 96(6A):59G-67G. PubMed ID: 16181824
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of chronic heart failure with positive inotropic agents].
    Lechat P.
    Therapie; 1989 Sep 19; 44(6):437-45. PubMed ID: 2576155
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.